000 | 01861 a2200541 4500 | ||
---|---|---|---|
005 | 20250513061444.0 | ||
264 | 0 | _c19931104 | |
008 | 199311s 0 0 eng d | ||
022 | _a0960-8931 | ||
024 | 7 |
_a10.1097/00008390-199306000-00005 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _avon Stamm, U | |
245 | 0 | 0 |
_aEffects of systemic interferon-alpha (IFN-alpha) on the antigenic phenotype of melanoma metastases. EORTC melanoma group cooperative study No. 18852. _h[electronic resource] |
260 |
_bMelanoma research _cJun 1993 |
||
300 |
_a173-80 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aAntibodies, Monoclonal |
650 | 0 | 4 |
_aAntigens, Neoplasm _xanalysis |
650 | 0 | 4 |
_aCell Adhesion Molecules _ximmunology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHLA-DR Antigens _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aIntercellular Adhesion Molecule-1 |
650 | 0 | 4 |
_aInterferon-alpha _xpharmacology |
650 | 0 | 4 | _aKi-67 Antigen |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMelanoma _xdrug therapy |
650 | 0 | 4 | _aMelanoma-Specific Antigens |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Proteins _xanalysis |
650 | 0 | 4 |
_aNuclear Proteins _ximmunology |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aPigmentation _xdrug effects |
650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
700 | 1 | _aBröcker, E B | |
700 | 1 | _avon Depka Prondzinski, M | |
700 | 1 | _aRuiter, D J | |
700 | 1 | _aRümke, P | |
700 | 1 | _aBroding, C | |
700 | 1 | _aCarrel, S | |
700 | 1 | _aLejeune, F J | |
773 | 0 |
_tMelanoma research _gvol. 3 _gno. 3 _gp. 173-80 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00008390-199306000-00005 _zAvailable from publisher's website |
999 |
_c8103894 _d8103894 |